Cargando…
Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with neoadjuvant chemotherapy
OBJECTIVE: To correlate changes in the apparent diffusion coefficient (ADC) from diffusion-weighted (DW)-MRI and standardised uptake value (SUV) from fluorothymidine ((18)FLT)-PET/CT with histopathological estimates of response in patients with non-small cell lung cancer (NSCLC) treated with neoadju...
Autores principales: | Carlin, Dominic, Weller, Alexander, Kramer, Gem, Liu, Yan, Waterton, John C, Chiti, Arturo, Sollini, Martina, Joop de Langen, A, O’Brien, Mary E R, Urbanowicz, Maria, Jacobs, Bart KM, deSouza, Nandita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592464/ https://www.ncbi.nlm.nih.gov/pubmed/33178953 http://dx.doi.org/10.1259/bjro.20190029 |
Ejemplares similares
-
MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423)
por: Jackson, Alan, et al.
Publicado: (2023) -
Preclinical Applications of 3'-Deoxy-3'-[(18)F]Fluorothymidine in Oncology - A Systematic Review
por: Schelhaas, Sonja, et al.
Publicado: (2017) -
(18)F-fluorothymidine PET imaging in gliomas: an update
por: Nikaki, Alexandra, et al.
Publicado: (2017) -
Patients’ findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT
por: Sollini, Martina, et al.
Publicado: (2021) -
Synthesis and evaluation of 3′-[(18)F]fluorothymidine-5′-squaryl as a bioisostere of 3′-[(18)F]fluorothymidine-5′-monophosphate
por: Brickute, D., et al.
Publicado: (2021)